2
Y.-S. Fang et al. / Steroids 100 (2015) 1–4
27
The anomeric proton coupling constant of 7.8 Hz indicated
21
20
the b-configuration of the glucopyranosyl [21], whose absolute
configuration was confirmed to be D on the basis of the acid
hydrolysis of 1 with 1 M HCl and the GC analysis of their
trimethylsilyl L-cysteine derivatives. Therefore, the structure of
1 was determined as (25S)-5b-spirostan-2b,3b-diol 3-O-b-D-glu-
26
25
O
22
18
12
11
23
24
17
R3
1
13
14
O
19
10
OH
6'
16
R1
O
2
8
9
6
15
3
5'
O
5
7
1'
copyranoside and named tuberosine A.
R5O
4
4'
R2
2'
Compound 2,
a white amorphous powder, exhibited the
3'
pseudomolecular ion peak at m/z 609.3641 [M-H]ꢀ in the
HO
OR4
1
R1=OH, R2=R3=R4=R5=H
2 R1=R3=OH, R2=R4=R5=H
3 R1=OH, R2=R3=R4=H, R5=α-L-Rha
HRESIMS data, corresponding to the molecular formula
C
33H54O10. A detailed comparison of the 1H, 13C NMR chemical shift
(Table 1) of 1 and 2, revealed that 2 was also a spirostanol steroidal
saponin with a b-glucopyranosyl group at C-3. The main difference
between them was that compound 2 possessed only one angular
methyl group which was one less than 1. Meanwhile, compound
2 exhibited the signals of an additional oxygenated CH2 group
(dH 3.40 d, J = 11.6 Hz; 3.87 d, J = 11.6 Hz; dC 65.2 t) in its NMR
spectra. Combining with its molecular formula, there might be a
hydroxy group substituted at C-18 or C-19 in compound 2. The
absence of the angular methyl group at about 24 ppm indicated
that the hydroxy group should be located at C-19, which was fur-
ther supported by the HMBC correlations from H-19 to C-1 (dC 33.3
t), C-5 (dC 41.9 d), C-9 (dC 29.2 d), and C-10 (dC 41.9 s) (Fig. 2). On
4
R1=R2=OH, R3=R4=R5=H
5 R1=R2=R3=R5=H, R4=β-D-Glc
6
R1=R2=R3=H, R4=β-D-Glc, R5=α-L-Rha
Fig. 1. Structures of compounds 1–6.
HMBC correlations of anomeric proton H-10 (dH 4.27 d, J = 7.8 Hz)
with C-3 (dC 80.3) and H-3 (dH 3.99 m) with anomeric carbon C-
10 (dC 103.8) (Fig. 2). The sugar was assigned as glucopyranosyl
moiety on the basis of a set of characteristic six carbon signals at
dC 103.8, 78.9, 78.8, 75.6, 72.5, 63.5 in the 13C NMR spectrum.
Table 1
acid hydrolysis, 2 afforded
analysis of its trimethylsilyl
2 was established as (25S)-5b-spirostan-2b,3b,19-triol 3-O-b-D-
D
-glucose, which was identified by GC
-cysteine derivative. Thus, compound
NMR spectral data of 1 (1H: 600 MHz; 13C: 150 MHz) and 2 (1H: 400 MHz; 13C:
L
100 MHz) in CD3OD.
Position
1
1
2
glucopyranoside and named tuberosine B.
Compound 3, a white amorphous powder, gives a molecular for-
mula of C39H64O13 by HRESIMS (negative ion mode) at m/z
739.4271 [M-H]ꢀ. Its spectral features and physicochemical
properties suggested 3 to be a spirostanol saponin. Compound 3
containing 39 carbons, including 27 of the aglycon part and 12 of
the oligosaccharide moiety. Comparison of the NMR data of 3 with
those of 1 (Table 2) revealed that they shared the same skeleton
and same glycosidic position at C-3. The molecular weight of 3
was 146 mass units greater than that of 1 indicating that 3 had
an additional deoxyhexose group, which was identified as a rham-
nose by its NMR data (dH 4.80 brs, 1.23 d, J = 6.0 Hz; dC 102.9 d, 73.7
d, 72.4 d, 72.2 d, 70.6 d, 17.8 d) [19]. The HMBC correlation
between H-100 (dH 4.80 brs) and C-40 (dC 79.6) (Fig. 2) proved the
(1 ? 4) linkage between glucose and rhamnose. The evaluation
of chemical shifts and spin–spin couplings of two anomeric
protons allowed the identification of one b-glucopyranose and
dC
dH (J in Hz)
dC
dH (J in Hz)
40.8
1.65 m
1.41 m
3.58 m
3.99 m
1.77 m
1.61 m
1.30 m
1.98 m
1.39 m
1.31 m
1.24 m
1.57 m
1.77 m
–
1.49 m
1.31 m
1.72 m
1.17 m
–
1.17 m
1.92 m
1.20 m
4.35 m
1.71 m
0.75 s
0.97 s
33.3
1.80 m
1.53 m
3.63 m
4.02 m
1.94 m
1.21 m
1.38 m
1.81 m
1.24 m
1.43 m
1.05 m
1.59 m
2.14 m
–
1.55 m
1.34 m
1.72 m
1.14 m
–
1.14 m
1.86 m
1.66 m
4.36 m
1.71 m
0.74 s
2
3
4
68.8
80.3
32.4
68.0
78.5
32.4
5
6
43.3
27.6
41.9
26.4
7
27.8
27.2
8
9
10
11
37.6
37.9
38.6
23.0
36.5
29.2
41.9
22.0
12
42.1
41.4
one
glucose was determined as
described above. Therefore, the structure of 3 was determined as
(25S)-5b-spirostan-2b,3b-diol 3-O- -rhamnopyranoyl-(1 ? 4)-
O-b- -glucopyranoside and named tuberosine C.
a-rhamnopyranose [2]. The absolute configuration of
13
14
15
42.6
58.3
33.5
41.6
57.8
30.9
D
and that of rhamnose as , as
L
a-L
16
17
18
19
83.3
64.5
17.8
24.9
82.4
63.4
16.9
65.2
D
It’s worthy to note that all the three new spirostanol steroidal
saponins (1–3) possess an unusual b-hydroxy substitution at C-2,
which is normally a-orientation in this kind of compounds.
The antimicrobial activities of the isolated compounds against
Escherichia coli, Bacillus subtilis have also been investigated
(Table 3). The results showed that 5 and 6 exhibited potent antibac-
3.87 d (11.6)
3.40 d (11.6)
1.82 m
0.95 d (7.2)
–
20
21
22
23
44.3
15.6
111.1
28.5
1.81 m
0.95 d (6.6)
–
1.42 m
1.04 m
1.87 m
1.39 m
1.63 m
3.88 dd (10.8, 2.4)
3.23 (9.6, 7.8)
1.05 d (7.2)
4.27 d (7.8)
3.20 m
3.23 m
3.23 m
3.31 m
3.81 m
43.4
14.7
111.2
26.9
Ha1.90 m; Hb1.34 m
terial activities against B. subtilis (32
(positive control, kanamycin: 2 g/mL). New saponin 2 showed
moderate antibacterial activities against B. subtilis (64 g/mL) and
E. coli (64 g/mL). Compounds 1, 3, and 4 showed no or only very
weak growth inhibition against above two microbes.
lg/mL) and E. coli (16 lg/mL)
24
27.8
26.6
1.93 m
1.34 m
1.67 m
3.87 dd (10.2, 2.4)
3.24 dd (10.2, 7.2)
1.04 d (6.8)
4.28 d (8.0)
3.24 m
3.35 m
3.26 m
3.26 m
3.81 m
l
l
25
26
29.4
66.9
28.3
66.1
l
27
10
20
30
40
50
60
17.2
103.8
75.6
78.8
72.5
78.9
63.5
16.4
102.4
74.6
77.6
71.6
77.8
62.6
Those saponins having a saccharide moiety at C-3 without any
oxygen functionalities at C-2 (5 and 6) exhibited potent antibacter-
ial activities, indicating 2-OH was negative to antibacterial activi-
ties. Compound 2, possessing a 2-OH, exhibited moderate
antibacterial activities, probably because of the existence of 19-
OH. 4 showed no antibacterial activities indicating 5-OH has no
positive effect on antibacterial activities.
3.60 m
3.63 m